Выбор редакции

Novartis's $475,000 cancer breakthrough heralds new era of cures

Novartis's $475,000 cancer breakthrough heralds new era of curesThe approval of Novartis AG’s breakthrough therapy for a deadly form of leukemia opened the door to a new class of treatments even as its $475,000 price tag reignited the debate on how to value potentially ...